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Critical roles of nardilysin in the maintenance
of body temperature homoeostasis
Yoshinori Hiraoka1,*,w, Tatsuhiko Matsuoka1,*, Mikiko Ohno1, Kazuhiro Nakamura2, Sayaka Saijo1,
Shigenobu Matsumura3, Kiyoto Nishi1, Jiro Sakamoto1, Po-Min Chen1, Kazuo Inoue3, Tohru Fushiki3,
Toru Kita4, Takeshi Kimura1 & Eiichiro Nishi1
Body temperature homoeostasis in mammals is governed centrally through the regulation
of shivering and non-shivering thermogenesis and cutaneous vasomotion. Non-shivering
thermogenesis in brown adipose tissue (BAT) is mediated by sympathetic activation, followed
by PGC-1a induction, which drives UCP1. Here we identify nardilysin (Nrd1 and NRDc) as a
critical regulator of body temperature homoeostasis. Nrd1 / mice show increased energy
expenditure owing to enhanced BAT thermogenesis and hyperactivity. Despite these findings,
Nrd1 / mice show hypothermia and cold intolerance that are attributed to the lowered set
point of body temperature, poor insulation and impaired cold-induced thermogenesis.
Induction of b3-adrenergic receptor, PGC-1a and UCP1 in response to cold is severely
impaired in the absence of NRDc. At the molecular level, NRDc and PGC-1a interact and co-
localize at the UCP1 enhancer, where NRDc represses PGC-1a activity. These findings reveal a
novel nuclear function of NRDc and provide important insights into the mechanism of
thermoregulation.
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T
hermoregulation is one of the most precisely regulated
homoeostatic functions in mammals, as hyperthermia or
hypothermia beyond the normal range can rapidly turn
into a life or death situation. Under cold stress, mammals
maintain their euthermic body temperature by preventing heat
loss and producing extra heat through shivering and non-
shivering (adaptive) thermogenesis. Brown adipose tissue (BAT)
is a specific organ for adaptive thermogenesis and its principal
function is to generate heat through an oxidative process not
coupled to ATP synthase, but mediated by the mitochondrial
uncoupling protein 1 (UCP1)1–3. The sympathetic nervous
system (SNS) regulates lipolysis and UCP1 expression in BAT,
and vasoconstriction in skin, both of which are critical factors for
balancing heat production and heat loss1,4. The SNS also
modulates the expression of peroxisome proliferator-activated
receptor g co-activator-1a (ppargc1a and PGC-1a), which is an
indispensable regulator for cold-induced upregulation of UCP1
(refs 5,6). Although essential roles of the SNS and PGC-1a/UCP1
pathway have been confirmed by the cold intolerance phenotype
of knockout mice lacking the gene for dopamine b-hydroxylase7,
b-adrenergic receptors (b-ARs)8, PGC-1a6 or UCP1 (ref. 2), the
molecular mechanisms of how this pathway is regulated in vivo
have not been precisely defined.
Adaptive thermogenesis is a major component of energy
expenditure. As obesity occurs when energy intake exceeds energy
expenditure, increasing the expenditure by enhancing adaptive
thermogenesis could lead to the prevention of obesity9. While the
physiological relevance of BAT in human adults was
controversial, recent studies by positron emission tomography
have clearly shown its presence and metabolic function10–13.
Regulatory factors of adaptive thermogenesis in BAT, thus, might
be a potential therapeutic target for obesity9,14.
Nardilysin (N-arginine dibasic convertase; Nrd1 and NRDc) is
a zinc peptidase of the M16 family, which selectively cleaves
dibasic sites15,16. Enzymatic activity of NRDc appears to be
required for antigen processing and the generation of cytotoxic
T-lymphocyte epitopes17. NRDc is mainly localized in the
cytoplasm as it has no apparent signal sequence, but a
significant proportion is secreted through an unconventional
secretory pathway and distributed on the cell surface18. We
identified NRDc on the cell surface as a specific binding partner
of heparin-binding epidermal growth factor (EGF)-like growth
factor (HB-EGF), and demonstrated that NRDc enhances the
ectodomain shedding of HB-EGF and other membrane proteins
through the activation of A disintegrin and metalloproteinase
(ADAMs)19–22. Furthermore, critical roles of NRDc as an
enhancer of shedding have been implicated in nervous system
development23, Alzheimer’s disease24 and cancer biology25.
Interestingly, NRDc has been demonstrated to shuttle between
the cytosol and nucleus26,27 and NRDc has been recently
identified as a dimethyl-H3K4-binding protein, suggesting a
novel role of NRDc in transcriptional regulation28.
Here we demonstrate that NRDc-deficient (Nrd1 / ) mice
show hypothermia and severe cold intolerance, which are
attributed to lowered set point of body temperature, poor
thermal insulation and impaired cold-induced BAT thermo-
genesis. Our studies also revealed that NRDc and PGC-1a
interact and co-localize in the UCP1 enhancer where NRDc
regulates PGC-1a activity and UCP1 transcription. These results
indicate that NRDc critically regulates body temperature homo-
eostasis, in part, through the modulation of PGC-1a activity.
Results
Hypothermia and severe cold intolerance in Nrd1 / mice.
We previously reported that Nrd1 / mice show growth
retardation23. Analysis of body composition of Nrd1 / mice by
cross-sectional computed tomography (CT) revealed a lean
phenotype of Nrd1 / mice (Fig. 1a). The ratios of body fat
mass to total body weight (BW) and to lean mass were
significantly reduced in Nrd1 / mice compared with
Nrd1þ /þ littermates (Fig. 1b,c). As these results suggested a
negative energy balance in Nrd1 / mice, we examined food
intake and energy expenditure. While both Nrd1þ /þ and
Nrd1 / mice showed similar ad libitum food intake per BW
(Fig. 1d), average energy expenditure, measured as oxygen
consumption (VO2), was 28.5% higher in Nrd1 / mice
(Fig. 1e). During a whole day ad libitum feeding, VO2 per total
BW of Nrd1 / mice was consistently higher than that of
Nrd1þ /þ mice (Fig. 1f). Two major components of energy
expenditure are physical activity and adaptive thermogenesis4.
Monitoring of animal movement showed that Nrd1 / mice are
more active than Nrd1þ /þ mice (Fig. 1g), partially explaining
the enhanced energy expenditure of Nrd1 / mice. To
determine whether increased adaptive thermogenesis
contributes to the enhanced energy expenditure, we examined
the resting core body temperature and cold tolerance of
Nrd1 / mice. Unexpectedly, even at room temperature
(23 C), the core body temperature of Nrd1 / mice was
significantly lower than that of Nrd1þ /þ mice (Nrd1þ /þ :
38.0±0.08 C, Nrd1 / : 36.4±0.14 C, the mean±s.e.m.,
measured in light period, n¼ 6, Po0.0001, two-tailed Student’s
t-test; Fig. 1h).
We next exposed 3-month-old Nrd1þ /þ and Nrd1 / mice
to 4 C. Mice on both genotypes responded to cold exposure by
shivering, indicating that Nrd1 / mice could sense the cold
temperature. Nrd1 / mice showed severe and prolonged
shivering at 1.5 h after the initiation of cold exposure
(Supplementary Movie 1), whereas Nrd1þ /þ mice showed
minimal shivering (Supplementary Movie 2). These observations
suggested that adaptive thermogenesis in Nrd1 / mice is
impaired. Whereas Nrd1þ /þ mice kept their body temperature
at around 36.5 C by the end of 3 h cold exposure after an initial
drop of B1.5 C, Nrd1 / mice were surprisingly intolerant to
cold exposure as their body temperature dropped below 30 C
within 2 h and below 15 C within 3 h (Fig. 1i). As a control, we
exposed younger Nrd1þ /þ mice that had similar BW similar to
3-month-old Nrd1 / mice to 4 C. As expected, younger
Nrd1þ /þ mice were able to maintain their body temperature at
around 36.5 C by the end of 3 h cold exposure, indicating that
cold intolerance of Nrd1 / mice is not merely because of their
smaller body mass (Supplementary Fig. 1).
Cold-induced thermogenesis is impaired in Nrd1 / mice. To
clarify the underlying mechanism of hypothermia and cold intol-
erance in Nrd1 / mice, we first examined the histopathology of
BAT, which generates heat mainly through the mitochondrial
uncoupler, UCP1. Unexpectedly, we found that lipid accumulation
in BAT was substantially lower in Nrd1 / than Nrd1þ /þ mice
at postnatal day 30 (P30), P90 and even at P180 (Fig. 2a). Electron
microscopy at P14 showed that the size of lipid vacuoles was much
smaller in Nrd1 / BAT, which resulted in the reduced cell size
and relative increase of the mitochondrial density in Nrd1 /
adipocytes (Fig. 2b). Electron micrograph images at a higher
magnification revealed no structural abnormality in the mito-
chondria of Nrd1 / BATs (Fig. 2c). Notably, much more
capillary vessels with larger diameters were found in Nrd1 /
BAT (Fig. 2b), indicating that Nrd1 / BAT is supplied with
more blood flow compared with Nrd1þ /þ BAT. The vascular-rich
phenotype was not observed in other tissues such as the liver and
skin, implying an increased oxygen requirement specifically for
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BAT. In spite of the hypothermic phenotype of Nrd1 / , these
histological features indicate that Nrd1 / BAT is metabolically
more active, producing more heat than Nrd1þ /þ BAT. To
examine whether NRDc is involved in adipogenic differentiation,
primary culture of preadipocytes was prepared from Nrd1þ /þ
and Nrd1 / BAT and differentiated into adipocytes. Cellular
morphology was similar and oil red O staining revealed no clear
differences in lipid accumulation between the two genotypes,
indicating that NRDc is not involved in adipogenic differentiation
(Supplementary Fig. 2a,b).
Cold-induced thermogenesis is mediated through the sympa-
thetic activation of b3-AR (Adrb3) on brown adipocytes, which is
followed by induction of a transcriptional co-activator PGC-1a,
resulting in increased expression of UCP1 (refs 1,4). In PGC-1a-
deficient BAT, cold-induced upregulation of UCP1 is markedly
reduced, indicating that the PGC-1a/UCP1 pathway is essential
for adaptive thermogenesis6. Consistent with the histological
findings, messenger RNA (mRNA) levels of PGC-1a, UCP1 and
b3-AR at room temperature were significantly higher in Nrd1 /
BAT (Fig. 3a). However, while Ppargc1a, Ucp1 and Adrb3 in
Nrd1þ /þ BAT were dramatically induced by cold exposure,
Ppargc1a and Ucp1 were not induced and Adrb3 was significantly
decreased in Nrd1 / BAT (Fig. 3a). As the blunted induction
suggested that cold-induced adaptive thermogenesis is impaired in
Nrd1 / mice, we measured BAT temperature (TBAT) in vivo
under cold exposure. Repeated skin cooling consistently increased
TBAT in Nrd1þ /þ mice, but not in Nrd1 / mice, confirming
that adaptive thermogenesis is severely impaired in Nrd1 /
BATs in vivo (Fig. 3b; Supplementary Table 1). However, the
tachycardic response to cooling was intact in Nrd1 / mice,
indicating that cutaneous temperature sensation is normal in
Nrd1 / mice (Fig. 3b; Supplementary Table 1).
Poor insulation and lowered set point in Nrd1 / mice. As
the thermoneutral zone for mice is around 30 C, mice have to
generate heat at room temperature (23 C) to maintain their body
temperature29. The lean phenotype of Nrd1 / mice suggest
that they are poorly insulated, which may cause enhanced
adaptive thermogenesis to compensate lost heat. To explore this
possibility, we measured VO2 of 6-month-old Nrd1 / mice at
23 and 30 C. Similar to 3-month-old mice (Fig. 1f), VO2 of
6-month-old Nrd1 / mice was significantly higher than that of
Nrd1þ /þ mice at 23 C. Notably, Nrd1 / mice showed
hypermetabolism even at 30 C, albeit the difference in energy
expenditure between Nrd1þ /þ and Nrd1 / mice was smaller
at 30 C (Fig. 4a–c). As the slope of increasing metabolism with
decreasing ambient temperature shows the level of insulation29,
these results indicate that Nrd1 / mice are less insulated than
Nrd1þ /þ mice (Fig. 4e). Simultaneous monitoring of physical
activities demonstrated that Nrd1 / mice are more active than
Nrd1þ /þ mice at night, but not at daytime (Fig. 4a,b,d).
Therefore, the higher VO2 of Nrd1 / mice, at least at daytime,









































































































































Figure 1 | Increased energy expenditure, hypothermia and cold intolerance of Nrd1 / mice. (a) Representative CT sections of abdominal regions
of 3-month-old Nrd1þ /þ and Nrd1 / mice. Scale bars, 10mm. (b,c) Ratio of total fat to BW (b) or to lean mass (c) was calculated from CT scan
data. Pink areas show visceral fat, while yellow areas show subcutaneous fat. n¼ 3 per genotype. (d) Food intake was measured daily for 7 days and
normalized to BW. n¼ 5 per genotype. (e,f) VO2 of 3-month-old Nrd1þ /þ and Nrd1 / mice was monitored in 10min intervals for 24 h (f) and the
average VO2 for 24 h is shown (e). n¼6 per genotype. (g) Physical activity was monitored for 7 days. The average movement counts are shown. n¼6 per
genotype. (h,i) Body temperature of 3-month-old Nrd1þ /þ and Nrd1 / mice at room temperature (h) and after cold (4 C) exposure (i). n¼ 6 per
genotype. All data represent means±s.e.m. *Po0.05, **Po0.005, ***Po0.001, wPo0.0001, NS, not significant (two-tailed Student’s t-test).
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BAT mRNA levels of UCP1 and b3-AR in Nrd1 / mice
showed clear tendencies to be higher than Nrd1þ /þ mice even
after 10 days housing at 30 C, although no difference in PGC-1a
was observed under this condition (Supplementary Fig. 3). These
findings indicated that BAT thermogenesis is primarily enhanced
in the mutant mouse, and further enhanced to compensate poor
insulation at room temperature.
To test the capacity of BAT thermogenesis at thermoneutrality,
we next examined the effect of b3 agonist on the metabolism at 23
and 30 C. At 23 C, Nrd1þ /þ mice responded to b3 agonist
injection with a sharp increase of VO2, whereas Nrd1 / mice
showed high basal metabolism and did not respond to b3 agonist
injection (Fig. 5a,c). In contrast, at 30 C, Nrd1 / mice
responded to b3 agonist from the decreased basal level
(Fig. 5b,c). These results indicated that Nrd1 / mice can
induce BAT thermogenesis, at least, in the narrow range of higher
ambient temperature around 30 C.
If hypothermia of Nrd1 / mice at 23 C is merely due to
impaired BAT thermogenesis, their body temperature may rise
when they are in the thermoneutral zone. However, the 1.5 C
difference in body temperature between Nrd1þ /þ and Nrd1 /
mice was still evident at 30 C and even at 33 C (Fig. 5d). These
results suggest that the hypothermia of Nrd1 / mice is caused
by lowered set point of body temperature.
To rule out the possibility that impaired cold-induced
thermogenesis is due to the reduced lipid substrate in
Nrd1 / BAT, we fed mice with a high-fat diet (HFD). After





















Figure 2 | Decreased lipid accumulation and increased blood vessels in Nrd1 / BAT. (a) Haematoxylin and eosin-stained sections of BATof Nrd1þ /þ
and Nrd1 / mice at P30, P90 and P180. Scale bars, 100mm. (b) Electron micrographs of BAT at P14. The same set of pictures, in which blood vessels
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Figure 3 | Impaired cold-induced thermogenesis in Nrd1 / mice. (a) Quantitative reverse transcription–PCR analysis for genes involved in adaptive
thermogenesis in BAT before (23 C) and after 3 h cold exposure (4 C). The mRNA level is normalized by b-actin mRNA, and the level is arbitrarily
set at 1 in Nrd1þ /þ BATat room temperature. n¼6 per genotype. (b) Representative trunk skin cooling (Tskin)-evoked changes in TBAT, heart rate (HR) and
Trec. All data represent means±s.e.m. *Po0.05, **Po0.005, NS, not significant (two-tailed Student’s t-test).
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dramatic increase in BAT lipid accumulation similar to Nrd1þ /þ
mice (Supplementary Fig. 4). Nrd1 / mice, however, were
unable to increase their body temperature even when the fuel
source for heat production was overloaded by HFD. These results
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Figure 4 | VO2 at different ambient temperature indicates poor insulation of Nrd1
 / mice. (a,b) VO2 (upper) and physical activities (lower) of
Nrd1þ /þ and Nrd1 / mice were monitored at 23 C (a) or 30 C (b). n¼6 per genotype and temperature. (c,d) The average VO2 (c) and activities
(d) during dark and light period of Nrd1þ /þ and Nrd1 / mice housed at 23 or 30 C. n¼ 6 per genotype and temperature. (e) Relationship
between metabolic rates and ambient temperature. The average VO2 of Nrd1
þ /þ (white) and Nrd1 / (black) mice was plotted against ambient
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Figure 5 | b3 agonist-induced VO2 and body temperature of Nrd1 / mice. (a,b) VO2 induced by b3 agonist (BRL-37344: 5mgkg 1) in Nrd1þ /þ and
Nrd1 / mice housed at 23 C (a) or 30 C (b). n¼ 6 per genotype and temperature. (c) The average VO2 of Nrd1þ /þ and Nrd1 / mice before
(Pre) and after (Post) b3-agonist injection at 23 or 30 C. n¼ 6 per genotype and temperature. (d) Body temperature of Nrd1þ /þ and Nrd1 / mice housed
at 23, 30 or 33 C. n¼ 5 per genotype and temperature. All data represent means±s.e.m. ***Po0.001, NS, not significant (two-tailed Student’s t-test).
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NRDc regulates PGC-1a and its downstream target genes.
While in vivo analysis at the thermoneutrality suggested that BAT
thermogenesis is primarily upregulated in Nrd1 / mice, NRDc
ablation in neural or hormonal systems might have indirectly
affected thermogenesis. To assess the direct effects of NRDc on
BAT thermogenesis, we measured the expression level of PGC-
1a, UCP1 and b3-AR in brown adipocyte primary cultures
treated with microRNA (miR) targeting NRDc. Similar to the
expression pattern in Nrd1 / BAT in vivo at room tempera-
ture, NRDc-knocked down cells showed increased mRNA levels
of PGC-1a, UCP1 and b3-AR (Fig. 6a) and increased protein
levels of UCP1 (Fig. 6b), indicating the cell autonomous
repressive effect of NRDc on the expression of these thermogenic
factors. Next, we examined the effect of forskolin, an activator
of PKA, on ppargc1a and Ucp1 induction in immortalized brown
adipocytes derived from Nrd1þ / and Nrd1 /
BAT. The basal mRNA levels of PGC-1a and UCP1 were
significantly higher in Nrd1 / cells compared with Nrd1þ /
cells, whereas levels induced by forskolin were similar in
Nrd1þ / and Nrd1 / brown adipocytes (Fig. 6c). These
results indicate that the regulation of ppargc1a and Ucp1 is
impaired in Nrd1 / BAT both in vivo and in vitro.
We next examined the direct effect of NRDc on the
transcriptional activity of ppargc1a. Luciferase reporter assay
using a 2-kb mouse ppargc1aa promoter30 showed that NRDc
overexpression significantly inhibits the forskolin-induced
transcriptional activity of ppargc1a, confirming that NRDc
negatively regulates ppargc1a transcription (Fig. 6d). As PGC-
1a is a transcriptional co-activator that functions as a master
regulator of oxidative metabolism31, we next asked whether gene
knockdown of NRDc affects target genes of PGC-1a other than
Ucp1. mRNA levels of multiple genes involved in the
mitochondrial oxidative metabolism were increased by gene
knockdown of NRDc in a primary culture of brown adipocytes
(Fig. 6e). Notably, the same set of oxidative genes was also
upregulated in Nrd1 / BAT in vivo (Fig. 6f). Results from these
gain and loss of function studies establish that NRDc is an
important upstream regulator of PGC-1a.
NRDc in the UCP1 enhancer negatively regulates PGC-1a
activity. NRDc shuttles between the cytosol and nucleus26,27.
Recent data have also demonstrated that NRDc is a dimethyl-
H3K4-binding protein with transcriptional repressor activity28.
Thus, we examined whether nuclear NRDc is directly involved in
the transcriptional regulation of PGC-1a. We confirmed the
nuclear expression of NRDc in brown adipocytes by western
blotting of nuclear fractions (Fig. 7a) and immunocytochemical
analysis (Fig. 7b). The specificity of the anti-mouse NRDc
monoclonal antibody used in these experiments was validated
using cells derived from Nrd1 / mouse (Supplementary
Fig. 5a). Nuclear expression of NRDc was also detected in BAT
of wild-type mice (Supplementary Fig. 5b). Furthermore, nuclear
NRDc was quickly reduced by isoproterenol treatment for 2 h
(Fig. 7a). The decrease of nuclear NRDc probably occurred at the
post-translational level, because mRNA level of NRDc was not
affected either by forskolin treatment in brown adipocytes or by
cold exposure in mice (Figs 6c and 3a). On the other hand,
protein levels of b3-AR and UCP1 did not change by the
treatment (Fig. 7a), although mRNA levels were upregulated by
forskolin (Fig. 6c).
The recruitment of PGC-1a to the peroxisome proliferator-
activated receptor-responsive element (PPRE) in the promoter
has been shown to be critical for transcriptional activation of
Ucp1 (refs 32–34). Chromatin immunoprecipitation (ChIP)
assay using anti-PGC-1a monoclonal antibodies showed that the
association of PGC-1a with Ucp1 promoter is clearly increased
by gene knockdown of NRDc in brown adipocytes (Fig. 7c).
These results indicated that NRDc not only controls the


























































































































































































Figure 6 | NRDc regulates transcription of PGC-1a and its downstream target genes. (a) mRNA levels of thermogenic genes in primary brown
adipocytes transduced with lentivirus vector expressing either a control miR or miRs targeted to Nrd1. n¼6. (b) Protein levels of NRDc and UCP1 in primary
brown adipocytes described in a. Full blots are presented in Supplementary Fig. 9. (c) mRNA levels of PGC-1a and UCP1 in mature immortalized
brown adipocytes derived from Nrd1þ / and Nrd1 / BAT in the presence or absence of forskolin treatment for 2 h. n¼ 6. (d) Transcriptional activity of
ppargc1a promoter-driven reporter gene in response to NRDc expression in the presence or absence of forskolin treatment in COS7 cells. n¼ 5. (e) mRNA
levels of PGC-1a target genes in primary brown adipocytes transduced with lentivirus vector as described in a. n¼ 6. (f) mRNA levels of PGC-1a
target genes in BAT of 12-week-old Nrd1þ /þ and Nrd1 / mice. n¼ 6. All data represent means±s.e.m. *Po0.05, **Po0.005, ***Po0.001, NS, not
significant (two-tailed Student’s t-test).
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promoter region of Ucp1. ChIP analysis also showed that
NRDc binds to the PPRE in the Ucp1 promoter, which was
significantly decreased by b-agonist treatment (Fig. 7d).
These results demonstrated that the transcriptional activation
of Ucp1 is accompanied with the removal of NRDc from its
enhancer region. As ChIP analysis indicated that both NRDc
and PGC-1a exist in the PPRE of Ucp1 promoter, we performed
sequential ChIP–re-ChIP experiments to determine the in vivo
co-localization of NRDc and PGC-1a. Sequential immunopre-
cipitation by antibodies against NRDc and PGC-1a demon-
strated that the two factors co-localize in the PPRE of Ucp1
enhancer (Fig. 7e).
We next assessed whether NRDc and PGC-1a physically
interact by two methods. First, immunoprecipitation with either
anti-FLAG (FLAG-PGC-1a) or anti-V5 (NRDc-V5) demon-
strated that NRDc and PGC-1a co-immunoprecipitate from co-
transfected cell lysates (Fig. 8a; Supplementary Fig. 6). Second,
pull-down assays demonstrated that recombinant NRDc binds to
PGC-1a protein containing the first 400 amino acids (Fig. 8b).
Finally, the effect of NRDc on the transcriptional co-activator
function of PGC-1a was assessed by the reporter activity driven
by Gal4-PGC-1a (ref. 5). NRDc repressed the transcriptional
activity of Gal4-PGC-1a in a dose-dependent manner when
introduced into COS7 cells with Gal4-PGC-1a (Fig. 8c). To assess
whether enzymatic activity of NRDc is required for the repressor
function, mouse embryonic fibroblast (MEF) cells isolated from
Nrd1 / mice were used for the reporter assay. Re-introduction
of wild-type NRDc, but not an enzymatically inactive mutant,
repressed Gal4-PGC-1a-induced transcriptional activity.
Altogether, these findings establish that NRDc binds to
PGC-1a and negatively regulates PGC-1a activity through its
metalloendopeptidase activity.
Discussion
In this study, we demonstrate that Nrd1 / mice show
hypothermia and severe cold intolerance. At room temperature
(23 C), Nrd1 / mice showed increased energy expenditure.
The histological features and upregulated expression of UCP1
in Nrd1 / BAT indicated that Nrd1 / BAT produces
more heat at room temperature than Nrd1þ /þ BAT. Enhanced
energy expenditure of Nrd1 / mice is, thus, due to
increased thermogenesis and hyperactivity. Despite these features,
Nrd1 / mice were severely intolerant to cold. Several
independent criteria suggested that this is due to impaired cold-
induced BAT thermogenesis and poor thermal insulation in
Nrd1 / mice. We found that cold induction of PGC-1a and
UCP1 was almost completely lost in Nrd1 / BAT. Our data
also indicated that skin cooling- and b3 agonist-induced heat
production in BAT are markedly reduced in Nrd1 / mice.
Furthermore, Nrd1 / mice showed severe and prolonged
shivering even at 1.5 h after the initiation of cold exposure, which
may be an attempt to compensate for the impaired BAT
thermogenesis. These results suggested that thermogenesis in
Nrd1 / BAT reaches a plateau at room temperature and
cannot be further induced by cold exposure. This interpretation
was also supported by the observation that VO2 of Nrd1 /
mice at 23 C was as high as that of Nrd1þ /þ mice after b3
agonist injection. The metabolism of Nrd1 / mice, however,
was markedly reduced in the thermoneutral zone (30 C). The
difference of VO2 between Nrd1þ /þ and Nrd1 / mice was
narrowed by raising the ambient temperature, although metabo-
lism of Nrd1 / mice was still significantly higher than that of
Nrd1þ /þ mice at 30 C. These results indicate that BAT
thermogenesis is primarily enhanced in the mutant mouse, and





















































































































Figure 7 | NRDc coexists with PGC-1a at the UCP1 enhancer. (a) Western blot analysis of cytosolic and nuclear fraction of mature brown adipocytes
treated for 2 h with or without isoproterenol (ISO) by indicated antibodies. Full blots are presented in Supplementary Fig. 9. (b) Mature brown
adipocytes stained with anti-NRDc antibody and 4’,6-diamidino-2-phenylindole were visualized by confocal microscopy. Scale bars, 20 mm. (c) ChIP
with anti-PGC-1a antibody followed by qPCR demonstrates that Nrd1 knockdown in mature brown adipocytes increases PGC-1a recruitment to PPRE of
the UCP1 enhancer. Results were normalized with input DNA, and are shown as the ratio to that in the control miR-treated cells (IP: aPGC-1a). n¼ 5.
(d) ChIP with anti-NRDc antibody followed by qPCR demonstrates that ISO treatment decreases NRDc binding to PPRE of the UCP1 enhancer. Results
are shown as the fold induction relative to that in cells without ISO treatment (IP: Control IgG). n¼4. (e) ChIP/re-ChIP analysis was performed with
anti-NRDc and PGC-1a antibodies followed by qPCR targeting the PPRE of the UCP1 enhancer. n¼ 3. All data represent means±s.e.m. *Po0.05,
(two-tailed Student’s t-test).
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temperature. It is not clear at present why Nrd1 / mice are
poorly insulated because the appearance and microstructure of
skin appear normal in Nrd1 / mice (data not shown).
Although Nrd1 / mice respond normally to cold by shivering
and increasing their heart rate, cold-induced cutaneous vasocon-
striction and/or pilomotor reflex might be impaired, which are
subjects of future studies.
Notably, in the thermoneutral zone, b3 agonist-induced
thermogenesis was rescued in Nrd1 / mice. These results
indicate that Nrd1 / mice can normally produce heat, at least, at
the limited range of high ambient temperature around 30 C. In
spite of the normal thermogenic capacity, body temperature of
Nrd1 / mice stayed 1.5 C lower than that of Nrd1þ /þ mice at
30 C, and even at 33 C. These results indicate that hypothermia
of Nrd1 / mice is not due to the impaired thermogenesis, but
probably due to the downregulation of the central set point of body
temperature. In addition, body temperature of Nrd1 / mice
remained the same after high fat feeding, which induced a
remarkable increase of BAT lipid accumulation, further supporting
the lowered set point of body temperature in Nrd1 / mice. As
NRDc is expressed in neurons and regulates axonal maturation
and myelination23, neuronal abnormalities of Nrd1 / mice may
contribute to the central setting of body temperature. To the best of
our knowledge, among genetically modified mice, only thyroid
hormone receptor a-deficient (TRa / ) mice have been reported
to have a lower set point of body temperature35. Given that PGC-
1a was shown to interact with TRb and activate its transcriptional
activity5,36, NRDc might cooperate with TR for the central
regulation of body temperature.
One of the most debated issues on the analysis of energy
expenditure is how to normalize VO2 for differences in BW29.
The BW of Nrd1 / mice is approximately half as much as that
of Nrd1þ /þ mice owing to the severe growth retardation
(Supplementary Fig. 7a). Since there is no complete method for
comparing metabolism of animals with such different BW, we
had to draw conclusion by unifying several results of different
experimental approaches. Nrd1 / mice showed hyperactivity,
enhanced BAT thermogenesis and decreased body fat, whereas
their food intake per BW was similar to that of Nrd1þ /þ mice.
Considering the energy balance, these results certainly indicate
that energy expenditure is increased in Nrd1 / mice. While
VO2 per BW was reasonably higher in Nrd1 / mice, VO2 per
animal was consistently lower in Nrd1 / mice relative to
Nrd1þ /þ mice owing to the small body size of Nrd1 / mice
(Supplementary Fig. 7b–d). These observations justify the usage
of VO2 per BW for this specific case. Furthermore, VO2 per BW
of Nrd1þ /þ mice at 23 C reached the very same level as that of
Nrd1 / mice after b3-agonist injection. VO2 per BW of
Nrd1þ /þ and Nrd1 / mice at 30 C was also similar after
b3-agonist injection. Since the excess amount of b3 agonist
should induce the maximum level of thermogenesis, these results
indicated that Nrd1þ /þ and Nrd1 / mice have a similar
maximum capacity of metabolism per BW. On the other
hand, VO2 per animal in Nrd1 / mice was lower than that
in Nrd1þ /þ mice both before and after b3-agonist injection
because of the small body size (Supplementary Fig. 7e–g). These
observations also support the use of VO2 per BW for the
metabolism index.
In addition to the in vivo analysis demonstrating the primary
effect of NRDc on BAT thermogenesis, our in vitro studies also
established the cell autonomous effect of NRDc on the expression
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Figure 8 | NRDc binds to PGC-1a and negatively regulates its transcriptional activity. (a) COS7 cells were transfected with the indicated expression
vectors, followed by immunoprecipitation of the co-transfected cell lysates with anti-FLAG (PGC-1a) antibody. Twenty percent of input was blotted
with anti-V5 (NRDc) in the bottom lane. Full blots are presented in Supplementary Fig. 9. (b) Pull-down assay using recombinant mouse NRDc and GST
fusion proteins containing the first 400 amino acids of PGC-1a immobilized on glutathione-Sepharose beads. After the incubation, the beads were boiled
and the eluted proteins were stained with Coomassie (left panel) and blotted with anti-NRDc (right upper panel) or anti-PGC-1a (right lower panel)
antibody. Full blots are presented in Supplementary Fig. 9. (c) Luciferase reporter assay using COS7 cells transfected with Gal4-PGC-1a and different dose
of NRDc. n¼ 5. (d) Luciferase reporter assay using MEF/ cells transfected with Gal4-PGC-1a and wild-type NRDc (WT) or enzymatically inactive
NRDc (E4A). Protein expression of WT and E4A in cell lysates was confirmed by western blot with anti-NRDc antibody (bottom panel). Full blots
are presented in Supplementary Fig. 9. n¼ 5. All data represent means±s.e.m. *Po0.05, **Po0.01, ***Po0.001, NS, not significant (two-tailed
Student’s t-test).
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regulates the PGC-1a/UCP1 pathway by two distinct mechan-
isms: regulation of ppargc1a transcription and PGC-1a recruit-
ment to the promoter of Ucp1. Although a direct interaction of
endogenous NRDc with endogenous PGC-1a remains to be
demonstrated, our data suggest that NRDc represses PGC-1a
activity and Ucp1 transcription by binding to PGC-1a. On
activation, removal of NRDc from the complex derepresses the
co-activator function of PGC-1a, allowing it to activate Ucp1
transcription (upper panel: Supplementary Fig. 8). In the absence
of NRDc, the basal levels of PGC-1a and UCP1 activation are
upregulated. However, further activation of PGC-1a and UCP1
by b-stimulant is impaired in the absence of NRDc (lower panel:
Supplementary Fig. 8). How b-stimulant regulates the interaction
of NRDc and PGC-1a remains to be determined.
The stability and activity of PGC-1a are known to be regulated
by post-translational mechanisms, such as acetylation and
phosphorylation37–39. Thus, removal of NRDc might facilitate
PGC-1a modification by enzymes, such as kinases, followed by
PGC-1a activation possibly through the recruitment of the
histone acetyltransferase complex40. Alternatively or
concurrently, NRDc may inhibit PGC1a activity by modulating
the co-repressor function of the NCoR/SMRT complex. We
found that the three subunits of NCoR/SMRT complex: SMRT,
NCoR and HDAC3 are associated with NRDc28. Although the
precise functions of NCoR and HDAC3 in BAT biology have yet
to be fully defined, these observations suggest that NRDc may
control thermogenesis by modulating the activity of the co-
activator and co-repressor complex on the UCP1 promoter.
We identified NRDc as a cell surface-binding partner of HB-
EGF19. Our subsequent studies demonstrated that NRDc enhances
the ectodomain shedding of not only HB-EGF but also of amyloid
precursor protein, tumour necrosis factor-a and neuregulin-1 (refs
20–23). Critical roles of NRDc as an enhancer of shedding have
been implicated in nervous system development23, Alzheimer’s
disease24 and cancer biology25. While the metalloendopeptidase
activity of NRDc is dispensable for the enhancement of ectodomain
shedding20, NRDc was shown to be required for antigen processing
and the generation of cytotoxic T-lymphocyte epitopes through its
enzymatic activity17. On the other hand, NRDc has been identified
as a novel histone-binding protein, specifically recognizing
dimethyl-H3K4 (ref. 28). It remains to be determined whether
the regulatory role of NRDc on PGC-1a, described in the present
study, is related to the dimethyl-H3K4-binding capacity. Although
we show here that the metalloendopeptidase activity of NRDc is
required for its repressing effect on PGC-1a activity, there is no
experimental evidence for the cleavage of PGC-1a by NRDc. The
enzymatic activity might alter, for example, the nuclear uptake of
NRDc. Future studies addressing the exact mechanism by which the
enzymatic activity regulates transcription are needed. Given the
observed localization-dependent multiple functions of NRDc, it will
be important to clarify the trafficking mechanism of NRDc in
future.
Methods
Animal experiments. Nrd1 / mice (accession number CDB0466K, http://
www.cdb.riken.jp/arg/mutant%20mice%20list.html) were generated by gene tar-
geting in TT2 (ref. 41) embryonic stem cells. The targeting vector was designed to
replace exon 1 with DT-A/lox71/LacZ-pA/frt/PGK-Neo/frt/loxP/pA cassette
(http://www.cdb.riken.jp/arg/cassette.html)23. Twelve-week-old Nrd1þ /þ and
Nrd1 / mice (both male and female) were used unless otherwise indicated.
All animal experiments were performed according to procedures approved by the
Institute of Laboratory Animals, the Kyoto University. Mice were maintained on a
diet of standard rodent chow or a high-fat/high-sucrose diet (Oriental yeast,
F2HFHSD) in environmentally controlled rooms.
Body fat composition analysis. For CT analysis of body fat composition, Nrd1þ /þ
and Nrd1 / mice were anaesthetized and scanned by LaTheta experimental animal
CT system (LCT-100M, Aloka). Body fat mass was analysed quantitatively using
LaTheta software (version 1.00) according to the manufacturer’s protocol42.
Respiratory gas analysis. Nrd1þ /þ and Nrd1 / mice were held individually
in a chamber at 23 or 30 C for a week so that they could attain a constant
respiratory exchange ratio. Gas analysis was performed using an open-circuit
metabolic gas analysis system connected directly to a mass spectrometer (Model
Arco2000; ArcoSystem)43. The VO2 was calculated using the following equations:
VO2¼ [(FEN2/FIN2) FIO2 FEO2]VT 10 where FEN2 is the concentration
of nitrogen in the exhaust air, FIN2 is the concentration of nitrogen in the room air,
FEO2 is the concentration of oxygen in the exhaust air, FIO2 is the concentration of
oxygen in the room air and VT is the air flow through the chamber corrected to
standard temperature pressure dry. To measure b-agonist-induced thermogenesis,
the b3-adrenergic agonist BRL-37344 (Sigma) was injected intraperitoneally at
5mg kg 1, and VO2 was measured for another 300min.
Cold tolerance test. For cold exposure, 12-week-old Nrd1þ /þ and Nrd1 /
female mice and 3-week-old Nrd1þ /þ female mice were individually housed in
cages at 4 C for 3 h. Core body temperature was monitored by a rectal temperature
(Trec) probe (Physitemp). After cold exposure, BAT was dissected and collected
immediately.
Skin cooling experiment. The procedures for rats described elsewhere44 were
modified to mice. Female mice, 8–12-month old, were anaesthetized with
intraperitoneal urethane (1.3 g kg 1) following introductory gas anaesthesia with
3% isoflurane. To monitor skin temperature, the trunk was shaved and a copper-
constantan thermocouple was taped onto the abdominal skin. The trunk was
placed on a plastic water jacket and the abdominal skin was cooled by perfusing the
water jacket with ice-cold water and then rewarmed by switching to perfusion with
warm water. Trec was monitored using a thermocouple inserted into the rectum.
Trec was maintained by perfusing the water jacket with warm or cold water. TBAT
was monitored with a needle-type thermocouple inserted into the interscapular
BAT pad.
Cell culture and viral infection. COS7 cells were grown in DMEM (4.5 g l 1
glucose) supplemented with 10% fetal bovine serum (FBS) and antibiotics (culture
medium). Brown preadipocytes were prepared from neonatal C57BL/6J mice as
reported elsewhere45. In brief, interscapular BATs were minced and digested with
2mgml 1 collagenase for 1 h at 37 C. Digested tissues were filtered through a
100-mm cell strainer to remove undigested tissues. The flow-through was then
centrifuged at 800 g for 10min to pellet the stromal vascular cells (preadipocytes).
The cells were then resuspended and plated onto a culture dish. To knock down
Nrd1 in brown preadipocytes, cells were infected with a lentivirus expressing miR-
targeting Nrd1 (BLOCK-iT miR RNAi Select; Life Technologies). Brown
preadipocytes were also established from neonatal Nrd1þ /þ , Nrd1þ / and
Nrd1 / mice. These preadipocytes were immortalized by infection of retrovirus
expressing SV40 T antigen followed by selection with G418. Adipogenic
differentiation was performed as described elsewhere46. In brief, cells were grown
to confluence in DMEM (4.5 g l 1 glucose) supplemented with 10% FBS,
antibiotics and 17mM pantothenic acid, 33mM biotin, 100 mM ascorbic acid, 1 mM
octanoic acid and 50 nM 3,30 ,5-triiodo-L-thyronine (adipocyte culture medium).
Differentiation was induced by treating confluent cells for 48 h in adipocyte culture
medium supplemented with 10mgml 1 insulin and 2.5 mM dexamethasone. After
induction, the culture medium was changed to adipocyte culture medium
supplemented only with 10mgml 1 insulin and cells were cultured for following
96 h. All experiments with the brown fat cells were performed after differentiation,
unless otherwise indicated. MEF cells were isolated from Nrd1 / embryos at
embryonic day 14.5 (E14.5), and were maintained in DMEM containing 5% FBS,
100Uml 1 of penicillin, 100mgml 1 of streptomycin and 2mM L-glutamine.
MEF were passed according to the 3T3 protocol and immortalized23.
Antibodies and immunoblot analysis. Rat anti-mouse NRDc monoclonal anti-
bodies (clone #1 and #135) and rabbit anti-mouse NRDc polyclonal antibody were
raised against recombinant mouse NRDc in our laboratory. Recombinant mouse
NRDc (full length) was synthesized using silkworm protein expression system
(Sysmex). Mouse anti-PGC-1a monoclonal antibodies (clone #3 and #16) were
raised against recombinant mouse PGC-1a (1-400) fused with glutathione S-
transferase (GST) in our laboratory. PGC-1a (1-400) fused with GST was prepared
in BL21 strain and synthesized according to the manufacturer’s instruction
(Amersham Biosciences). Other antibodies were from the following sources; UCP1
(Sigma, U6382), Lamin A/C (Santa Cruz, sc-6215), b3-adrenergic receptor
(Chemicon, AB5124) and b-actin (Santa Cruz, sc47778). For immunoblot analysis,
primary antibodies were used at the following dilutions: rat anti-mouse NRDc
monoclonal antibody (clone #1) at 1:2,000; rabbit anti-mouse NRDc polyclonal
antibody at 1:2,500; anti-PGC-1a monoclonal antibody (clone #16) at 1:2,000;
UCP1 at 1:1,000; Lamin A/C at 1:1,000; b3-adrenergic receptor at 1:1,000; b-actin
at 1:2,500. Preparation of total cell extract and immunoblot analysis were carried
out as described previously20. In brief, cells were lysed in lysis buffer containing
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10mM Tris–HCl pH 7.4, 150mM NaCl, 1% NP-40 and protease inhibitor cocktail
(Roche). Cell lysates were separated by SDS–polyacrylamide gel electrophoresis and
transferred to nitrocellulose filters. After blocking, filters were incubated with
primary antibodies, followed by horseradish peroxidase-conjugated secondary
antibodies. The immobilized peroxidase activity was detected with the enhanced
chemiluminescence system (Amersham Biosciences). For isolation of nuclei, brown
adipocytes were suspended in hypotonic buffer (10mM HEPES (pH 7.9), 1.5mM
MgCl2, 10mM KCl, 0.1mM EDTA, 0.1% NP-40, 1mM dithiothreitol, protease
inhibitor cocktail (Complete Mini; Roche) and phosphatase inhibitor cocktail
(Sigma)), followed by homogenization and centrifugation (2,500 r.p.m., 5min,
4 C). Extraction of nuclear fraction was carried out by resuspension of collected
nuclei in high salt buffer (20mM HEPES (pH 7.9), 1.5mM MgCl2, 400mM NaCl,
0.1mM EDTA, 10% glycerol, 0.1% NP-40, 1mM dithiothreitol, protease inhibitor
cocktail (Complete Mini; Roche) and phosphatase inhibitor cocktail (Sigma),
followed by centrifugation (20,400g, 5min, 4 C).
Immunostaining and oil red O staining. Immunocytochemistry was performed
as described previously20. In brief, fixed differentiated brown adipocytes were
immunostained with rat anti-mouse NRDc (clone #135 at 1:200 dilution) and
Alexa Fluor 488-conjugated goat anti-rat IgG antibodies (A-11006 at 1:500
dilution), followed by the counterstaining with 4’,6-diamidino-2-phenylindole.
Stained cells were observed with a Zeiss LSM510 META laser scanning confocal
microscope. Immunohistochemistry was performed with deparaffinized sections as
described previously23. In brief, mice were anaesthetized and transcardially
perfused with 4% paraformaldehyde (PFA) in PBS. Tissues were post-fixed in 4%
PFA for 16 h and embedded in paraffin and sectioned at 6 mm thickness on a
microtome. For oil red O staining, differentiated brown fat cells were fixed with
3.7% formaldehyde and stained with 0.3% (w/v) oil red O solution in 60%
isopropyl alcohol.
Electron microscopy. Mice were anaesthetized and fixed via transcardial perfusion
with 4% PFA and 2% glutaraldehyde in 0.1M phosphate buffer. A block of
B2mm3 of BAT was removed from interscapular area, incubated for 2 h at 4 C in
the same fixative and contrasted with 1% osmic acid in PBS. Tissues were dehy-
drated in an ethanol gradient from 50–100% and embedded in epon. Semi-thin
sections (0.9 mm) were stained with toluidine blue for survey by light microscopy.
Ultra-thin sections (80 nm) were cut and stained with 2% uranyl acetate (Watson’s
modified method) and Reynolds lead citrate, and analysed with HITACHI H-7650
transmission electron microscope.
Quantitative real-time PCR analysis. Total RNA was purified from snap-frozen
BAT and from differentiated brown adipocytes using Trizol reagent (Life Tech-
nologies) according to the manufacturer’s protocol. First-strand complementary
DNA was synthesized from total RNA using the Transcriptor First Strand cDNA
Synthesis Kit (Roche). Quantitative reverse transcription–PCR was carried out
using the ABI Prism 7700 Sequence Detection System and SYBR Green MASTER
(Roche) following the manufacturer’s directions (Applied Biosystems). The results
were standardized for comparison by measuring levels of Actb mRNA in each
sample. The primers used in these studies are shown in Supplementary Table 2.
Luciferase reporter assays. PGC-1a promoter 2 kb luciferase30 and Gal4-PGC-
1a (ref. 5) are generous gifts from B.M. Spiegelman. (UAS)x3-TK/luciferase and
Gal4-DBD are generous gifts from D. Moore. A cDNA encoding full length of
mouse NRDc was cloned into pcDNA3.1/V5-His to generate pcDNA3.1-mNRDc-
V5. A cDNA encoding an enzymatically inactive mutant of mouse NRDc was
obtained by substituting the Glu237 codon (GAG) with an Ala codon (GCG) using
the PCR technique (pcDNA3.1-mNRDc-E4A-V5). For luciferase assays, COS7 or
MEF cells were transiently transfected with various combinations of expression and
reporter plasmids using HilyMax (Dojindo). Forty eight hours after transfection,
cells were lysed and analysed by using the Dual-Luciferase Reporter Assay Kit
(Promega) according to the manufacturer’s protocol.
ChIP and Re-ChIP assay. Mature brown adipocytes were treated with or without
10mM isoproterenol for 2 h and crosslinked with 1% formaldehyde in culture
medium for 10min. Cells were collected and resuspended in hypotonic solution,
followed by isolation of nuclei, which were lysed in nuclear lysis buffer (50mM
Tris–Cl, pH 7.5, 150mM NaCl, 0.1% SDS, 1% Triton X-100, 1mM EDTA, 0.1%
sodium deoxycholate and protease inhibitors). ChIP assays were performed using
ChIP-IT Express Chromatin Immunoprecipitation Kits (Active Motif). In brief,
chromatin-bound proteins were immunoprecipitated with antibodies against
NRDc (rabbit polyclonal anti-mouse NRDc), PGC-1a (clone #3) or control IgG
(Abcam). One-twentieth of the purified DNA after ChIP was subjected to qPCR
analysis using following primers targeting the PPRE of the UCP1 enhancer: for-
ward 50-TCACCCTTGACCACACTGAA-30 , reverse 50-GTGAGGCTGATATCCC
CAGA-30 . Results were normalized with qPCR results using 1% of the total
chromatin subject to ChIP. For re-ChIP assay, immunoprecipitates were eluted
after the first ChIP. The eluate was diluted and subjected to the second ChIP.
GST pull-down assay. Plasmids, pGEX-PGC-1a (1-400), were a kind gift from
B.M. Spiegelman40. GST fusion proteins were prepared in BL21 strain and purified
on glutathione-Sepharose 4B (Amersham Biosciences). In pull-down assay, 15 ml of
a 50% slurry of GST fusion proteins bound to the beads were incubated with 500 ng
of recombinant mouse NRDc in 200 ml PBS containing 0.1mgml 1 BSA for
overnight at 4 C. The beads were washed and eluted proteins were analysed by
SDS–polyacrylamide gel electrophoresis followed by Coomassie blue staining and
immunoblotting.
Statistical analysis. All results are presented as the mean±s.e.m. Statistical
analyses were done by two-tailed Student’s t-test for comparisons of two groups.
Analysis of variance and appropriate post hoc analysis were used for comparisons
of more than three groups.
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